Effects of ibandronate: A Synthesis of Findings from 5 Studies

  1. Home
  2. Effects of ibandronate
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of ibandronate: A Synthesis of Findings from 5 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of ibandronate: A Synthesis of Findings from 5 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major research findings

Ibandronate is a bisphosphonate medication used to treat postmenopausal osteoporosis. Multiple studies have shown that ibandronate is effective in treating osteoporosis. 5 investigated the effect of stopping oral bisphosphonate treatment for postmenopausal osteoporosis (ibandronate, alendronate, risedronate) on BTMs and BMD. They found that after stopping treatment, all three groups showed an increase in BTMs and a decrease in hip BMD; however, none returned to pre-treatment baseline values. 1 delineated in detail the dose-dependent effects of intermittent intravenous (IV) ibandronate treatment on the dynamics of markers of bone resorption and formation. The study found that the higher the dose, the greater the suppression of bone resorption markers and the smaller the suppression of bone formation markers. 3 compared the effects of oral alendronate, ibandronate and risedronate on the central and peripheral skeleton over 2 years. They reported differences in effect on the central skeleton but not on the peripheral skeleton. Greater effects were observed for ibandronate (and alendronate) than risedronate at the spine but not the hip. 4 performed a meta-analysis on the efficacy of ibandronate by evaluating the effect sizes of different dosing regimens. The study found that ibandronate treatment significantly improved lumbar spine bone mineral density (BMD) as shown by the percent change from baseline (4.80%, P < 0.0001, 95% confidence interval [CI] [4.14, 5.45]). 2 found that oral ibandronate 50 mg significantly reduced the mean SMPR compared with placebo (0.95 vs 1.18, P=0.004). There was a significant reduction in the mean number of events requiring radiotherapy (0.73 vs 0.98, P<0.001) and events requiring surgery (0.47 vs 0.53, P=0.037). Poisson's regression analysis confirmed that oral ibandronate significantly reduced the risk of a skeletal event compared with placebo (hazard ratio 0.62, 95% CI=0.48, 0.79; P=0.0001). These research findings indicate that ibandronate is effective for treating osteoporosis and reducing the risk of skeletal complications in patients with breast cancer.

Benefits and Risks

Benefit Summary

Ibandronate is a bisphosphonate medication used to treat postmenopausal osteoporosis. It works by decreasing the breakdown of bone, which helps to increase bone density and reduce the risk of fractures. 5 , 1 , 3 , 4 , 2

Risk Summary

Ibandronate can cause gastrointestinal side effects such as nausea, heartburn, and stomach pain. It can also cause jawbone problems in some people. It is important to talk to your doctor about your risk factors before taking ibandronate. 2

Comparison between studies

Commonalities between studies

Multiple studies have shown that ibandronate is effective in treating postmenopausal osteoporosis. 5 , 1 , 3 , 4 , 2

Differences between studies

Ibandronate can be administered orally or intravenously. Some studies have investigated the relationship between the dosage of ibandronate and its effectiveness, while others have investigated the effects of discontinuing ibandronate treatment. The frequency and severity of side effects associated with ibandronate have also been reported to vary between studies. 5 , 1 , 3 , 4 , 2

Consistency and contradictions in results

While multiple studies have shown that ibandronate is effective in treating postmenopausal osteoporosis, there are some contradictions in the results. For example, the relationship between dosage and effectiveness, as well as the effects of discontinuing treatment, have been found to vary between studies. Furthermore, the frequency and severity of side effects associated with ibandronate have also been reported to vary. These contradictions require further investigation. 5 , 1 , 3 , 4 , 2

Considerations for application in real life

Ibandronate should be taken under the guidance of a physician, with appropriate dosage and administration methods. 2

Limitations of current research

There is not enough research on ibandronate. Further research is needed to determine the long-term safety and effectiveness of ibandronate. Additionally, further studies are required to investigate the relationship between dosage and effectiveness, as well as the effects of discontinuing treatment. 5 , 1 , 3 , 4 , 2

Future research directions

Research is needed to evaluate the long-term safety and effectiveness of ibandronate. Further studies are required to investigate the relationship between dosage and effectiveness, as well as the effects of discontinuing treatment. It is also important to evaluate the combined effects of ibandronate with other therapies. 5 , 1 , 3 , 4 , 2

Conclusion

Ibandronate is considered an effective medication for treating postmenopausal osteoporosis. However, it can cause gastrointestinal side effects and, in rare cases, jawbone problems. It is important to talk to your doctor before taking ibandronate. Further research on ibandronate is needed. 5 , 1 , 3 , 4 , 2

Literature analysis of 5 papers
Positive Content
4
Neutral Content
1
Negative Content
0
Article Type
4
1
0
1
5
1.

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.

Author: ChristiansenC, TankóL B, WarmingL, MoelgaardA, ChristgauS, QvistP, BaumannM, WieczorekL, HoyleN

Treats osteoporosis

Ibandronate is a bisphosphonate used to treat osteoporosis. This study looked at the effects of intermittent intravenous ibandronate on bone turnover markers in postmenopausal women. The results show that ibandronate effectively suppressed bone resorption, but the effect was not sustained. The suppression of bone formation was less than the suppression of bone resorption, which may contribute to the inefficacy of this dosing regimen.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies.

Author: BodyJ J, DielI J, LichinitzerM, LazarevA, PecherstorferM, BellR, TripathyD, BergstromB

Dosing convenience
Good tolerability
Prevention of skeletal complications
Upper GI AEs

Oral ibandronate, a bisphosphonate, was shown to be an effective and well-tolerated treatment for preventing skeletal complications in patients with metastatic bone disease. It offers similar efficacy to intravenous bisphosphonates with fewer side effects.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

3.

Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.

Author: PaggiosiM A, PeelN, McCloskeyE, WalshJ S, EastellR

Bone density increase

This study compared the effects of oral alendronate, ibandronate, and risedronate on bone health over 2 years. Ibandronate and alendronate were found to have a greater effect on the central skeleton (spine) than risedronate, while all three drugs had similar effects on the peripheral skeleton (hip). These findings suggest that ibandronate may be a more effective option for increasing bone density at the spine compared to risedronate.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis.

Author: HouYanjie, GuKe, XuChao, DingHuiyong, LiuChangxin, TuohetiYilihamu

Improved BMD
Reduced bone resorption
Ineffective doses

This meta-analysis evaluated the efficacy of ibandronate, a medication used to treat osteoporosis, across different dosing regimens. Ibandronate significantly improved bone mineral density in the lumbar spine and total hip.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

5.

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.

Author: NaylorK E, BradburnM, PaggiosiM A, GossielF, PeelN F A, McCloskeyE V, WalshJ S, EastellR

This study looked at the effects of stopping different types of bisphosphonate medications (ibandronate, alendronate, risedronate) used to treat osteoporosis in postmenopausal women. After stopping treatment, all groups experienced an increase in bone turnover markers (BTMs), indicating increased bone breakdown, and a decrease in bone mineral density (BMD) in the hip, although levels did not return to their original levels before treatment.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.